Abstract
Fanconi anemia (FA) should be included among the genetic diseases that occur at high frequency in the Ashkenazi Jewish population. FA exhibits extensive genetic heterogeneity; there are currently 11 complementation groups reported, and 8 (i.e., FANCA, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG, and FANCL) genes have been isolated. While patients may be from widely diverse ethnic groups, a single mutation in complementation group FA-C, c.711+4A>T (commonly known as IVS4+4A>T prior to current nomenclature rules) is unique to FA patients of Ashkenazi Jewish ancestry, and has a carrier frequency of greater than 1/100 in this population. In addition, a mutation (c.65G>A) in FANCA (FA-A is the most common complementation group in non-Jewish patients) and the mutation c.6174delT in FANCD1/BRCA2 are also unique to the Ashkenazi Jewish population. Therefore, the study of Fanconi anemia can lend insight into the types of cancer-predisposing genetic diseases specific to the Ashkenazi.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Verlander PC, Kaporis A, Liu Q et al. Carrier frequency of the IVS4 +4A>T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995; 86: 4034–8.
Levran O, Erlich T, Magdalena N et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA.1997; 94(24): 13051–6.
Neuhausen S, Gilewski T, Norton L et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996; 13: 126–8.
Auerbach AD, Buchwald M, Joenje H. Fanconi Anemia.In Vogelstein B, Kinzler, KW (eds).The Genetic Basis of Human Cancer, 2nd edition. New York: McGraw-Hill 2002; 289–306.
Butturini A, Gale RP, Verlander PC et al. Hematologic abnor-malities in Fanconi anemia.An International Fanconi Anemia Registry study. Blood 1994; 84: 1650–5.
Giampietro PF, Adler-Brecher B, Verlander PC et al. The need for more accurate and timely diagnosis in Fanconi anemia.A report from the International Fanconi Anemia Registry.Pediatr 1993; 91: 1116–20.
Giampietro PF, Verlander PC, Davis JG et al. Diagnosis of Fanconi anemia in patients without congenital malformations: an International Fanconi Anemia Registry study. Am J Med Genet 1996; 68: 58–61.
Kutler DI, Singh B, Satagopan J et al. A 20 year perspective of The International Fanconi Anemia Registry (IFAR).Blood 2003; 101: 1249–56.
Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101(3): 822–6.
Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB)test. Exp Hematol 1993; 21: 731–3.
Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis.In Dracopoli NC, Haines JL, Korf BR et al.(eds): Current Protocols in Human Genetics.New York: John Wiley & Sons 2003; Supplement 37, 8.7.1–8.7.15.
Verlander PC, Shin HT, Auerbach AD. Haplotype analysis of polymorphic markers surrounding the Fanconi anemia gene FAC: evidence for a founder effect for the IVS4 +4A>T mutation. Am J Hum Genet 1995; 57: A174.[abstract ].
Joenje H, Oostra AB, Wijker M et al. Evidence for at least eight Fanconi anemia genes.Am J Hum Genet 1997; 61(4): 940–4.
Hanenberg H, Batish SD, Pollok KE et al. Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 2002; 30: 410–20.
Maatei AR, de Winter JP, Medhurst AL et al. A novel ubiquitin ligase is defficient in Fanconi anemia. Nat Genet 2003; 35: 165–70.
Levitus M, Rooimans MA, Steltenpool J et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 2003; Nov 20 [Epub ahead of print ].
Yamashita T, Wu N, Kupfer G et al. Clinical variability of Fanconi anemia (type C)results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 1996; 87: 4424–32.
Gillio AP, Verlander PC, Batish SD et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 1997; 90: 105–10.
D' Andrea AD, Grompe M. The Fanconi anaemia/BRCA path-way. Nat Rev Cancer 2003; 1: 23–34.
Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia.Nat Rev Genet 2001; 6: 446–57.
Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi 's anaemia by functional complementation. Nature 1992; 356: 763–7[published erratum appears in Nature 1992; 358: 434 ].
Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1: 196–8.
Savoia A, Centra M, Ianzano L et al. Characterization of the 5 ¢ region of the Fanconi anemia group C (FACC)gene. Hum Mol Genet 1995; 4: 1321–6.
Whitney MA, Saito H, Jakobs PM et al. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 1993; 4: 202–5.
Verlander PC, Lin JD, Udono MU et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54: 595–601.
Gibson RA, Morgan NV, Goldstein LH et al. Novel mutations and polymorphisms in the Fanconi anaemia group C gene. Hum Mutat 1996; 8: 140–8.
Lo Ten Foe JR, Barel MT, Thuss P et al. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant.Hum Genet 1996; 98: 522–3.
Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA.Nat Genet 1996; 14: 320–3.
Fanconi Anaemia/Breast Cancer Consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet 1996; 14: 324–8.
Howlett NG, Taniguchi T, Olson S et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297: 606–9.
Wagner JE, Tolar J, Levran O et al. Germline Mutations in BRCA2: Shared Genetic Susceptibility to Breast Cancer, Early Onset Leukemia and Fanconi Anemia. Blood 2004; Jan 8 [Epub ahead of print ].
Hirsch B, Shimamura A, Moreau L et al. Biallelic BRCA2/ FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood 2003; Dec 11 [Epub ahead of print ].
Offit K, Levran O, Mullaney B et al. Shared Genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia in an extended family. J Natl Cancer Inst 2003; 95: 1548–51.
Oddoux C, Struewing JP, Clayton CM et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.Nat Genet 1996; 14(2): 188–90.
National Human Genome Research Insitute (NHGRI).An open access on-line breast cancer mutation database: an international collaborative effort hosted by NHGRI.Retrieved from http: // research.nhgri.nih.gov/bic/on 18 August 2003.
Mazoyer S, Dunning AM, Serova O et al. A polymorphic stop codon in BRCA2. Nat Genet 1996; 14(3): 253–4.
Kauff ND, Perez-Segura P, Robson ME et al. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 2002; 39(8): 611–4.
Wajnrajch MP, Gertner JM, Huma Z et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744–54.
Wagner JE, MacMillan ML, Auerbach AD. Hematopoietic cell transplantation in the treatment of Fanconi anemia.In Forman SJ, Blume KG, Thomas ED (eds): Hematopoietic Cell Transplanta-tion, 3rd edition. Malden: Blackwell Science 2003; 1483–4.
Auerbach AD, Liu Q, Ghosh R et al. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia. Transfusion 1990; 30: 682–7.
Auerbach AD. Umbilical cord blood transplants for genetic disease: diagnostic and ethical issues in fetal studies. Blood Cells 1994; 20: 303–9.
Verlinsky Y, Rechitsky S, Schoolcraft W et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001; 285: 3130–3.
Grewal SS, Kahn JP, MacMillan ML et al. Successful hemato-poietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preim-plantation genetic diagnosis. Blood 2004; 103: 1147–51.
Wolf SM, Kahn JP, Wagner JE. Using preimplantation genetic diagnosis to create a stem cell donor: issues, guidelines &limits. J Law Med Ethics 2003; 31(3): 327–39.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kutler, D.I., Auerbach, A.D. Fanconi anemia in Ashkenazi Jews. Familial Cancer 3, 241–248 (2004). https://doi.org/10.1007/s10689-004-9565-8
Issue Date:
DOI: https://doi.org/10.1007/s10689-004-9565-8